Objectives: We evaluated the mid-term results of treatment with curettage followed by an autograft or xenograft application in patients with enchondroma of the hand.
Methods and Material: Between 2013-2017, 24 patients (13 males, 11 females; mean age 32 years; range 18-74 years) were operated for enchondroma of the hand. Following curettage of the lesion, reconstruction of the defect was made either by an autograft obtained from the iliac crest (n=16) or by a bovine xenograft (n=8). Functional and radiographic results were assessed according to the QDASH scoring system and the Tordai classification system, respectively.
Results: In the autograft group, the grafts were seen to be radiologically incorporated at mean five weeks (range, 4-6 weeks). In the functional results, the mean QDASH score was 2.4. No residual pain was determined in any patient, and all patients achieved full ROM. In the xenograft group, the grafts were seen to be radiologically incorporated at mean 16 weeks (range, 12-24 weeks). In the functional results, the mean QDASH score was 5.2. Non-union or recurrence was not determined in any patient of either group at the final follow-up examination.
Conclusion: Clinically similar successful results were seen in the treatment of enchondroma in hand using autograft or xenograft. Due to the limited resources of autograft and the high costs of the synthetic matrix, the option of xenograft seems to be more sustainable for orthopedic problems.
Key words: Bone graft, hand enchondroma, xenografting
|
